Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency

Bone

Volumn 23, Issue 3, 1998, Pages 257-266

  Miller, M A ^a   Chin, J ^a   Miller, S C ^a   Fox, J ^a  

^a NPS Pharmaceutical Inc   (United States)

Author keywords

Cancellous bone; Cortical bone; Parathyroid gland; Rat; Renal osteodystrophy; Secondary hyperparathyroidism (2 HPT)

Indexed keywords

CALCITRIOL; CALCIUM; CREATININE; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BODY WEIGHT; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE STRENGTH; BONE TISSUE; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CANCELLOUS BONE; CELL HYPERPLASIA; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORTICAL BONE; CREATININE BLOOD LEVEL; FEMUR; MALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARTIAL NEPHRECTOMY; PERIOSTEUM; PHOSPHATE BLOOD LEVEL; PHYSICAL PHENOMENA; RAT; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM; SKELETON MALFORMATION; TIBIA;

ANIMALS; BODY WEIGHT; BONE DENSITY; CALCIUM, DIETARY; CELL COUNT; FEMUR; HYPERPARATHYROIDISM; HYPOCALCEMIA; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; PARATHYROID GLANDS; PARATHYROID HORMONE; PHOSPHORUS, DIETARY; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 0031696056     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00098-2     Document Type: Article

References (39)

1. Amling, M., Grote H. J., Vogel, M., Hahn, M., and Delling, G. Three-dimensional analysis of the spine in autopsy cases with renal osteodystrophy. Kidney Int 46:733-743; 1994.
2. Bover, J., Jara, A., Trinidad, P., Rodriguez, M., Martin-Malo, A., and Felsenfeld, A. J. The calcemic response to PTH in the rat: Effect of elevated PTH levels and uremia. Kidney Int 46:310-317; 1994.
3. Bover, J., Rodriguez, M., Trinidad, P., Jara, A., Martinez, M. E., Machado, L., Llach, F., and Felsenfeld, A. J. Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat. Kidney Int 45:953-961; 1994.
4. Chin, J., Conklin, R., Lowe, S., Petty, B., Nemeth, E. F., and Fox, J. NPS R-568 inhibits parathyroid cell hyperplasia and hypertrophy in rats with chronic renal insufficiency. J Am Soc Nephrol 7:1812; 1996 (abstract).
5. Chin, J., Miller, S. C., Nemeth, E. F., and Fox, J. The calcimimetic compound NPS R-568 reduces parathyroid cell and gland size but not cell number in rats with chronic renal insufficiency. J Bone Miner Res 11(Suppl. 1):S121; 1996 (abstract).
6. D'Amour, P. and Lazure, C. Metabolism of radioiodinated carboxyl-terminal fragments of bovine parathyroid hormone in normal and anephric rats. Endocrinology 117:127-134; 1985.
7. Denda, M., Finch, J., and Slatopolsky, E. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 28:596-602; 1996.
8. Fox, J., Chin, J., Nemeth, E. F., Furuya, Y., Ishii, H., Wada, M., and Nagano, N. Effects of a calcimimetic on the parathyroid glands of rats with chronic renal insufficiency and severe secondary hyperparathyroidism. J Am Soc Nephrol 8:573A; 1997 (abstract).
9. Frost, H. M. Bone histomorphometry: Analysis of trabecular bone dynamics. In: Recker, R. R., Ed. Bone Histomorphometry: Techniques and interpretation. Boca Raton, FL: CRC; 1983; 109-131.
10. Fukagawa, M., Kaname, S.-Y., Igarashi, T., Ogata, E., and Kurokawa, K. Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int 39:874-881; 1991.
11. 3 and its derivatives on experimental renal osteo dystrophy. Endocrinology 107:328-333; 1980.
12. Goodman, W. G., Coburn, J. W., Slatopolsky, E., and Salusky, I. Renal osteodystrophy in adults and children. In: Favus, M. J., Ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 3rd Edition. Philadelphia, PA: Lippincott-Raven; 1996; 341-360.
13. Gunderson, H. J. G., Bendtsen, T. F., Korbo, L., Marcussen, N., Moller, A., Nielsen, K., Nyengard, J. R., Pakenberg, B., Sorensen, F. B., Vesterby, A., and West, M. J. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96:379-394; 1988.
14. Jablonski, G., Danielsen, C. C., Mosekilde, L., and Gordeladze, J. O. Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption. Calcif Tissue Int 55:281-287; 1994.
15. 3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats. Calcif Tissue Int 57:385-391; 1995.
16. Lieuallen, W. G., Weisbrode, S. E., and Horst, R. L. The effects of major vitamin D metabolites upon the resolution of osteomalacia in uremic adult rats. Bone 11:267-273; 1990.
17. Malluche, H. H., Ritz, E., Lange, H. P., Kutschera, J., Hodgson, M., Seiffert, U., and Schoeppe, W. Bone histology in incipient and advanced renal failure. Kidney Int 9:355-362; 1976.
18. Malluche, H. and Faugere, M. C. Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 38:193-211; 1990.
19. Martin, K. J., Hruska, K. A., Freitag, J. J., Klahr, S., and Slatopolsky, E. The peripheral metabolism of parathyroid hormone. N Engl J Med 301:1092-1098; 1979.
20. Miller, S. C. and Jee, W. S. S. Ethane-1-hydroxy-1, 1-diphosphonate (EHDP) effects on growth and modeling of the rat tibia. Calcif Tissue Int 18:215-231; 1975.
21. Moscovici, A., Bernheim, J., Popovtzer, M. M., and Rubinger, D. Renal osteodystrophy in rats with reduced renal mass. Nephrol Dial Transplant 11(Suppl. 3):146-152; 1996.
22. Naveh-Many, T., Rahamimov, R., Livni, N., and Silver, J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96:1786-1793; 1995.
23. Parfitt, A. M. The hyperparathyroidism of chronic renal failure: A disorder of growth. Kidney Int 52:3-9; 1997.
24. Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., and Recker, R. R. Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610; 1987.
25. Rogers, K. V. and Fox, J. Parathyroid gland calcium receptor mRNA levels are unaffected by chronic renal insufficiency or low dietary calcium in rats. Endocrine 3:769-774; 1995.
26. 2D in rats with chronic renal failure is parathyroid hormone dependent. Proc Soc Exp Biol Med 195:13-17; 1990.
27. Rucinski, B., Mann, G. N., and Epstein, S. A new rapid and reproducible homologous immunoradiometric assay for amino-terminal parathyroid hormone in the rat. Calcif Tissue Int 56:83-87; 1995.
28. Sawaya, B. P., Koszewski, N. J., Qi, Q., Langub, M. C., Monier-Faugere, M.-C., and Malluche, H. H. Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure. J Am Soc Nephrol 8:271-278; 1997.
29. Schultz, V. L., Garner, S. C., Lavigne, J. R., and Toverud, S. U. Determination of bioactive rat parathyroid hormone (PTH) concentrations in vivo and in vitro by a 2-site homologous immunoradiometric assay. Bone Miner 27:121-132; 1994.
30. Sherrard, D. J., Hercz, G., Pei, Y., Maloney, N. A., Greenwood, C., Manuel, A., Saiphoo, C., Fenton, S. S., and Segre, G. V. The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney Int 43:436-442; 1993.
31. Silverberg, S. J., Gartenberg, F., Jacobs, T. P., Shane, E., Siris, E., Staron, R. B., and Bilezekian, J. P. Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 80:723-728; 1995.
32. Slatopolsky, E., Berkoben, M., Kelber, J., Brown, A. J., and Delmez, J. Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism. Kidney Int 38:S43-S49; 1992.
33. Slatopolsky, E., and Delmez, J. A. Pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 23:229-236; 1994.
34. 3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 35:1049-1056; 1989.
35. 3, 19-nor-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Am J Kidney Dis 30:105-112; 1997.
36. Wada, M., Furuya, Y., Sakiyama, J., Kobayashi, N., Miyata, S., Ishii, H., and Nagano, N. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor. J Clin Invest 100:2977-2983; 1997.
37. Wada, M., Ishii, H., Furuya, Y., Fox, J., Nemeth, E. F., and Nagano, N. NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int 53:448-453; 1998.
38. Weibel, E. R. Stereological Methods. San Francisco: Academic; 1979.
39. Yi, H., Fukagawa, M., Yamoto, H., Kumagai, M., Watanabe, T., and Kurokawa, K. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: Possible direct role of phosphorus. Nephron 70:242-248; 1995.